- Home
- WALD vs CBUS Comparison
WALD vs CBUS Comparison
Compare WALD & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WALD | CBUS |
|---|---|---|
| Founded | 1988 | 2010 |
| Country | United Kingdom | United States |
| Employees | 364 | N/A |
| Industry | Package Goods/Cosmetics | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 130.8M | 121.1M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | WALD | CBUS |
|---|---|---|
| Price | $0.97 | $1.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $2.00 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 1.2M | 613.9K |
| Earning Date | 03-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 74.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,639,000.00 |
| Revenue This Year | $9.89 | $112.72 |
| Revenue Next Year | $4.31 | $83.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.72 | $1.09 |
| 52 Week High | $3.22 | $4.19 |
Technical Indicators
Market Signals| Indicator | WALD | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 44.33 | 39.95 |
| Support Level | $0.86 | $1.43 |
| Resistance Level | $2.06 | $1.50 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 59.75 | 52.94 |
Price Performance
Historical ComparisonAbout WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About CBUS Cibus Inc.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.